Literature DB >> 23934703

Hepatitis B virus infection in clustering of infection in families with unfavorable prognoses in northwest China.

Yuan Yang1, Li Jin, Ying-Li He, Ke Wang, Xiao-Hua Ma, Jing Wang, Zhi Yan, Yu-Ling Feng, Yong-Qin Li, Tian-Yan Chen, Hong-Li Liu, Ying-Ren Zhao.   

Abstract

Hepatitis B virus (HBV) infection and its associated liver diseases have characteristics of familial clustering in China. However, the reasons for this are not understood fully. To address this issue, the prevalence HBV infection and the characteristics of unfavorable prognoses in clustering of infection in families in northwest China were investigated. Families with clustering of infection and unfavorable prognoses were enrolled, and general information and serum samples were collected. The clinical features and sequelae of HBV infection were compared among the blood relatives (including the first-, second-, and third-degree blood relatives) and spouses using the chi-square test or Fisher's exact test. A total of 102 clusterings of infection families with unfavorable prognoses were interviewed. In the first-, second-, and third-degree blood relatives and spouses, the prevalences of cirrhosis of the liver were 29.2%, 11.9%, and 8.7%, respectively, while those of hepatocellular carcinoma (HCC) were 21.8%, 1.4%, and 4.3%, respectively (P<0.05). The mean ages of the onset of cirrhosis of the liver in the first-, second-, and third-degree blood relatives and spouses were 57 ± 9.91, 47 ± 9.96, 38 ± 10.35, and 57 ± 8.49 years, respectively, while the mean ages of the onset of HCC were 60 ± 7.92, 49 ± 8.57, 41 ± 3.54, and 50 ± 0 years, respectively, (P<0.05). The first-, second-, and third-degree blood relatives from clustering of infection in families with unfavorable prognoses had prevalences of cirrhosis or HCC in descending order of relationship. The findings suggest that genetic factors may be associated with a familial tendency for cirrhosis of the liver and HCC.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  cirrhosis; family clustering; genetic factors; hepatitis B virus; hepatocellular carcinoma

Mesh:

Year:  2013        PMID: 23934703     DOI: 10.1002/jmv.23649

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  5 in total

1.  Low positivity rates for HBeAg and HBV DNA in rheumatoid arthritis patients: a case-control study.

Authors:  Yue Jia; Jingjing Zhang; Lingfei Mo; Bomiao Ju; Nan Hu; Yanhua Wang; Pei Wang; Jie Zheng; Lan He; Jing Wang
Journal:  BMC Infect Dis       Date:  2022-06-24       Impact factor: 3.667

2.  Psychological stress exerts effects on pathogenesis of hepatitis B via type-1/type-2 cytokines shift toward type-2 cytokine response.

Authors:  YingLi He; Heng Gao; XiaoMei Li; YingRen Zhao
Journal:  PLoS One       Date:  2014-08-21       Impact factor: 3.240

3.  Vatalanib, a tyrosine kinase inhibitor, decreases hepatic fibrosis and sinusoidal capillarization in CCl4-induced fibrotic mice.

Authors:  Ling-Jian Kong; Hao Li; Ya-Ju Du; Feng-Hua Pei; Ying Hu; Liao-Liao Zhao; Jing Chen
Journal:  Mol Med Rep       Date:  2017-03-15       Impact factor: 2.952

4.  The association of adverse outcomes in the mother with disease progression in offspring in families with clusters of hepatitis B virus infection and unfavorable prognoses in Northwest China.

Authors:  Yuan Yang; Li Jin; Zhen Tian; Dandan Guo; Naijuan Yao; Qian Li; Zicheng Jiang; Daokun Yang; Xianmei Tang; Hongbin Li; Yingli He; Jinfeng Liu; Tianyan Chen; Yingren Zhao
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

5.  Liver resection for young patients with large hepatocellular carcinoma: a single center experience from China.

Authors:  Xi-yu Liu; Jiang-feng Xu
Journal:  World J Surg Oncol       Date:  2014-06-03       Impact factor: 2.754

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.